Prostate cancer: 2-year ADT improves survival in patients receiving high-dose radiotherapy

Nat Rev Urol. 2015 Apr;12(4):181. doi: 10.1038/nrurol.2015.43. Epub 2015 Mar 10.
No abstract available

Publication types

  • Comment

MeSH terms

  • Adenocarcinoma / therapy*
  • Androgen Antagonists / administration & dosage*
  • Antineoplastic Agents, Hormonal / administration & dosage*
  • Chemoradiotherapy / methods*
  • Humans
  • Male
  • Prostatic Neoplasms / therapy*
  • Radiotherapy Dosage*
  • Radiotherapy, Conformal*

Substances

  • Androgen Antagonists
  • Antineoplastic Agents, Hormonal